Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.9K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.9K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

29
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
29

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age-related macular degeneration and cerebral amyloid angiopathy have similar pathologies from cholesterol-APOE-amyloid-β-complement mediated inflammation.

Progress in retinal and eye research·2026
Same author

Reply.

Ophthalmology·2025
Same author

Reprogramming Factors Activate a Non-Canonical Oxidative Resilience Pathway That Can Rejuvenate RPEs and Restore Vision.

bioRxiv : the preprint server for biology·2025
Same author

Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks.

Diabetes care·2025
Same author

Optimized Minimally Invasive Transscleral Subretinal Injection Technique in Mouse.

Journal of visualized experiments : JoVE·2025
Same author

The Sialome of the Retina, Alteration in Age-Related Macular Degeneration Pathology, and Potential Impacts on Complement Factor H.

Investigative ophthalmology & visual science·2025

Related Experiment Video

Updated: Feb 22, 2026

Enrichment of Bruch's Membrane from Human Donor Eyes
10:22

Enrichment of Bruch's Membrane from Human Donor Eyes

Published on: November 15, 2015

12.6K

Complement factor H in AMD: Bridging genetic associations and pathobiology.

Christopher B Toomey1, Lincoln V Johnson2, Catherine Bowes Rickman1

  • 1Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC 27710, USA; Department of Cell Biology, Duke University, Durham, NC 27710, USA.

Progress in Retinal and Eye Research
|September 21, 2017
PubMed
Summary

Age-Related Macular Degeneration (AMD) risk is linked to a specific gene variant. This CFH Y402H polymorphism may accelerate lipoprotein buildup in Bruch's Membrane, worsening drusen formation in AMD.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.8K
Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells
08:33

Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells

Published on: February 10, 2021

7.3K

Related Experiment Videos

Last Updated: Feb 22, 2026

Enrichment of Bruch's Membrane from Human Donor Eyes
10:22

Enrichment of Bruch's Membrane from Human Donor Eyes

Published on: November 15, 2015

12.6K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.8K
Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells
08:33

Efficient Dissection and Culture of Primary Mouse Retinal Pigment Epithelial Cells

Published on: February 10, 2021

7.3K

Area of Science:

  • Ophthalmology
  • Immunogenetics
  • Complement Biology

Background:

  • Age-Related Macular Degeneration (AMD) is a leading cause of vision loss.
  • Drusen and geographic atrophy (dry AMD) or neovascularization (wet AMD) characterize AMD.
  • The CFH Y402H polymorphism is strongly associated with AMD development.

Purpose of the Study:

  • To review the literature on the functional significance of the CFH Y402H polymorphism in AMD.
  • To propose a model for how CFH H402 influences AMD pathogenesis.
  • To discuss other complement components and mouse models relevant to AMD.

Main Methods:

  • Literature review of functional studies on CFH Y402H polymorphism.
  • Presentation of a proposed model based on the authors' group studies.
  • Review of existing literature on complement factors (C3a, C5a, MAC) and transgenic AMD models.

Main Results:

  • The functional significance of the CFH Y402H polymorphism remains incompletely understood.
  • Proposed model: CFH H402 impairs binding to heparan sulfate proteoglycans, promoting lipoprotein accumulation and drusen progression.
  • Other complement components and in vivo models are crucial for understanding AMD.

Conclusions:

  • The CFH Y402H polymorphism likely contributes to AMD pathogenesis through altered CFH binding and accelerated lipoprotein accumulation.
  • Further research using in vivo models is essential to validate these findings.
  • Understanding complement's role is key to developing AMD therapies.